6-APB: Difference between revisions

>FckDej
Reagent kit results: Added this heading + chart
>FckDej
m Correction of title
Line 158: Line 158:
*[https://erowid.org/experiences/subs/exp_6APB.shtml Erowid Experience Vaults: 6-APB]
*[https://erowid.org/experiences/subs/exp_6APB.shtml Erowid Experience Vaults: 6-APB]


== Reagent kit results<ref>https://www.protestkit.eu/results/</ref> ==
==Reagent kit results<ref>https://www.protestkit.eu/results/</ref>==
{| class="wikitable"
{| class="wikitable"
!Compound
!Compound
Line 197: Line 197:
|}
|}


==Toxicity and harmReagent kit results  potential==
==Toxicity and harm potential==
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
Due to only having a short history of human use, the toxicity and harm potential is not exactly known. Due to its similarity to MDMA, it is likely that the administration of repeated or high dosages of 6-APB may be both neurotoxic and cardiotoxic<ref>Drug-induced Valvulopathy: An Update | tpx.sagepub.com/content/38/6/837.full</ref><ref>Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17950805</ref> in some form.
Due to only having a short history of human use, the toxicity and harm potential is not exactly known. Due to its similarity to MDMA, it is likely that the administration of repeated or high dosages of 6-APB may be both neurotoxic and cardiotoxic<ref>Drug-induced Valvulopathy: An Update | tpx.sagepub.com/content/38/6/837.full</ref><ref>Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17950805</ref> in some form.
Retrieved from "http://psy.st/wiki/6-APB"